Visit us at booth 305 and attend our Expert Theater Session

The Role of anti-HMGCR Autoantibodies in Statin-Induced Myositis

Muscle biopsy or blood test? Join us for an enlightening session as Dr. Kaniecki highlights the significance of the anti-HMGCR autoantibody as an alternative to a muscle biopsy in diagnosing statin-induced necrotizing myositis. His session also outlines the exciting multi-disciplinary approach that led to this discovery, as well as the clinical impact the biomarker can have on improving patient care.

Date: June 1, 2024 at 8:00 AM 

Speaker: Timothy Kaniecki, MD 

Johns Hopkins Rheumatology

^{This event is not part of the National Lipid Association Scientific Sessions, as planned by the NLA Education Committee and is not being certified for CME/CE credit.}